Skip to main content

Wellington Management — Portfolio, Page 5

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

276
Companies
$58.1B
Total invested
$261.7M
Avg. check
60
Industries
Biotechnology 8Therapeutics 6Artificial Intelligence (AI) 5Health Care 5Financial Services 5FinTech 5+54 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 97120 of 276
TS Conductor
July 2024

TS Conductor specializes in high-performance conductors that increase the ampacity of electric transmission and distribution.

Electrical Distribution · Arcadia$60.0M Series B
GrayMatter Robotics
June 2024

GrayMatter Robotics provides AI-powered robotic solutions that enhance productivity and efficiency for high-mix manufacturers.

Artificial Intelligence (AI) · Gardena$45.0M Series B
Bluejay Therapeutics
May 2024

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

Biotechnology · San Mateo$182.0M Series C
BBOT
May 2024

BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3K malignancies.

Biopharma · Palo Alto$200.0M Venture - Series Unknown
Finvero
April 2024

Finvero is a fintech company, operating a consumer Lending MarketPlace Platform (SaaS format) connecting merchants, shoppers and lenders.

Consumer Lending · Mexico City$3.8M Venture - Series Unknown
Asher Bio
April 2024

Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.

Biotechnology · San Francisco$55.0M Series C
Trove
August 2023

Trove, commanding 75% of U.S. branded resale, empowers brands like Patagonia and Michael Kors to launch, manage, and scale resale programs

E-Commerce · Brisbane$30.0M Series E
Alkeus Pharmaceuticals
June 2023

Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.

Biotechnology · Cambridge$150.0M Series B
Clerkie
April 2023

Clerkie is an AI financial planner that provides financial knowledge, personalized answers, and actionable plans.

Artificial Intelligence (AI) · San Francisco$33.0M Series A
Compass
January 2026

Compass is a real estate technology company that provides an online platform for buying, renting, and selling real estate assets.

Property Management · New York$850.0M Post-IPO Debt
Voyager Therapeutics
January 2024

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Biotechnology · Cambridge$100.0M Post-IPO Equity
Butterfly Network
January 2025

Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.

Artificial Intelligence (AI) · Burlington$75.6M Post-IPO Equity
AMP
December 2024

AMP utilizes AI-powered sortation to enhance recycling efficiency and reduce costs.

Artificial Intelligence (AI) · Louisville$91.0M Series D
SoFi
December 2025

SoFi is a finance company that offers a range of lending and wealth management services.

Credit · San Francisco$1.5B Post-IPO Equity
Crescent Biopharma
December 2025

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

Biotechnology · Rockville$185.0M Post-IPO Equity
SiteOne Therapeutics
December 2024

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

Biotechnology · South San Francisco$100.0M Series C
Trade Republic
December 2025

Trade Republic helps Europeans for wealth creation through easy, secure, and free access to financial markets.

Consumer · Berlin$1.4B Secondary Market
Global Blood Therapeutics
December 2021

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

Biotechnology · South San Francisco$300.0M Post-IPO Debt
Olist
December 2021

Olist is an SMB commerce enabler ecosystem that specializes in the fields of logistics and capital.

E-Commerce · Curitiba$186.0M Series E
Binkey
December 2023

Binkey is a financial technology company that helps merchants to accepts FSA and HSA as a form of payment.

Financial Services · Washington$3.3M Seed
Dataiku
December 2022

Dataiku operates as an enterprise artificial intelligence and machine-learning platform.

Agentic AI · New York$200.0M Series F
nCino
January 2022

nCino provides a cloud banking platform that helps financial institutions modernize their operations and improve the customer experience.

B2B · Wilmington$925.6M Post-IPO Equity
Crisp
December 2025

Crisp ingests and delivers daily, actionable retail data from different sources, providing brands with visibility into inventory and sales.

Business Intelligence · Springdale$26.0M Series B
Kymera Therapeutics
December 2025

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Biotechnology · Cambridge$602.0M Post-IPO Equity

Where Wellington Management invests

Biotechnology8
Therapeutics6
Artificial Intelligence (AI)5
Health Care5
Financial Services5
FinTech5

About Wellington Management's portfolio

How many companies has Wellington Management invested in?

Wellington Management has invested in 276 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Wellington Management invest in?

Wellington Management's top investment sectors include Biotechnology, Therapeutics, Artificial Intelligence (AI), Health Care, Financial Services. The firm invests across 60 different industry categories.

What is Wellington Management's largest investment?

Among tracked funding rounds, SoFi received $1.5B in a Post-IPO Equity round. Wellington Management's total known invested capital is $58.1B.

What is the average investment size for Wellington Management?

Wellington Management's average investment size is $261.7M across its portfolio of 276 companies.

What are Wellington Management's most recent investments?

Recent Wellington Management portfolio additions include TS Conductor, GrayMatter Robotics, Bluejay Therapeutics, BBOT, Finvero. These companies were founded in 2020 or later.

Reach the founders behind these 276 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →